Knox Lane Makes Strategic Growth Investment in Spectrum Science

February 1, 2023

Knox Lane, a San Francisco-based growth investment firm, has made a strategic minority investment in Spectrum Science, an independent healthcare-focused marketing, communications and media firm. The investment will support Spectrum's expansion of strategic communications, clinical trial recruitment capabilities and technology enablement; Jonathan Wilson will remain CEO and serve as an Executive Member of the Board.

Buyers
Knox Lane
Targets
Spectrum Science
Sellers
Jonathan Wilson
Location
District of Columbia, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.